A number of new antidiabetes agents for type 2 diabetes have become available in recent years, and these have been accompanied subsequently by updated guidance from bodies such as NICE.  Many of us working in the primary care setting have now used these newer agents, and this series of complimentary, topical, afternoon updates provides a welcome opportunity to share our clinical experiences and best practice findings.  We shall also consider our approach to treament from the perspective of the person with diabetes - something that must not be forgotten in the midst of all the recent attention on therapeutics and glucose lowering targets.  Furthermore, we will offer a timely update for primary care practitioners on how to take a responsible approach to bariatric surgery, and we will also consider the antidiabetes agents for the future. If you are a primary care practitioner involved in the day-to-day management of type 2 diabetes we look forward to welcoming you to what promises to be a most productive and rewarding afternoon.

Martin Hadley-Brown, GP, Thetford and Chair, PCDS

Professor Anthony Barnett, Consultant Physician, Birmingham (Co-chairs)

Date of preparation:  December 2009

12-11 JAN/32234-09